Oculis Holding Correlations
OCS Stock | 16.16 0.79 5.14% |
The current 90-days correlation between Oculis Holding AG and Tff Pharmaceuticals is 0.24 (i.e., Modest diversification). The correlation of Oculis Holding is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Oculis Holding Correlation With Market
Good diversification
The correlation between Oculis Holding AG and DJI is -0.16 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Oculis Holding AG and DJI in the same portfolio, assuming nothing else is changed.
Oculis |
Moving together with Oculis Stock
0.69 | ESPR | Esperion Therapeutics | PairCorr |
0.84 | EWTX | Edgewise Therapeutics | PairCorr |
0.71 | BHC | Bausch Health Companies | PairCorr |
0.67 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.68 | EBS | Emergent Biosolutions | PairCorr |
0.74 | GANX | Gain Therapeutics | PairCorr |
0.78 | GILD | Gilead Sciences | PairCorr |
0.73 | CPRX | Catalyst Pharmaceuticals | PairCorr |
Moving against Oculis Stock
0.8 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.77 | ELAN | Elanco Animal Health Potential Growth | PairCorr |
0.73 | HLN | Haleon plc | PairCorr |
0.68 | TAK | Takeda Pharmaceutical | PairCorr |
0.63 | ZTS | Zoetis Inc | PairCorr |
0.62 | RDY | Dr Reddys Laboratories | PairCorr |
0.54 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.54 | LLY | Eli Lilly Sell-off Trend | PairCorr |
0.41 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.73 | ANRO | Alto Neuroscience, | PairCorr |
0.66 | LTRN | Lantern Pharma | PairCorr |
0.49 | SIGA | SIGA Technologies | PairCorr |
0.45 | CTLT | Catalent | PairCorr |
0.43 | AMGN | Amgen Inc | PairCorr |
0.43 | ANEB | Anebulo Pharmaceuticals | PairCorr |
Related Correlations Analysis
-0.05 | -0.75 | 0.07 | 0.85 | 0.44 | CUE | ||
-0.05 | 0.57 | 0.54 | 0.08 | -0.01 | TFFP | ||
-0.75 | 0.57 | 0.34 | -0.65 | -0.27 | ELYM | ||
0.07 | 0.54 | 0.34 | 0.14 | -0.16 | INBX | ||
0.85 | 0.08 | -0.65 | 0.14 | 0.16 | ELVN | ||
0.44 | -0.01 | -0.27 | -0.16 | 0.16 | MOLN | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Oculis Stock performing well and Oculis Holding Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Oculis Holding's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CUE | 7.68 | 1.25 | 0.19 | 1.35 | 5.91 | 20.27 | 67.78 | |||
TFFP | 6.89 | (1.75) | 0.00 | (1.33) | 0.00 | 11.28 | 95.77 | |||
ELYM | 3.87 | (0.92) | 0.00 | (2.63) | 0.00 | 6.21 | 34.87 | |||
INBX | 2.30 | 0.11 | 0.02 | 0.27 | 2.70 | 5.54 | 16.80 | |||
ELVN | 1.96 | 0.09 | 0.04 | 0.20 | 2.06 | 5.84 | 12.96 | |||
MOLN | 4.53 | (0.20) | 0.00 | (0.02) | 0.00 | 9.38 | 52.92 |
Oculis Holding Corporate Management
Daniel JD | Chief Officer | Profile | |
Ramin MD | Chief Officer | Profile | |
Virginia Dean | Chief Officer | Profile | |
Gudrun Bachmann | Chief Officer | Profile | |
Rebecca Weil | Chief Officer | Profile | |
Bastian MD | Chief Officer | Profile | |
Pll Jhannesson | Chief Officer | Profile |